Efficacy and safety of once-weekly cagrilintidesemaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a study, The Lancet Diabetes & Endocrinology, 14 , 8, (649-661), (2026)
Peer review Peer review information Nature Reviews Endocrinology thanks Thomas Lutz and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
Palgrave Macmillan
Self-administering unregulated peptides purchased online carries significant risks
Travel and Temperature Management For short-term travel (under 48 hours), use a medical-grade cooler with ice packs to maintain 28C
WARNINGS: Do not use if pregnant or planning to become pregnant or breastfeeding